Mahzi Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome (NCT07135050) | Mahzi Therapeutics | 2025-12-19 |
Track Mahzi Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.